ヒト血液凝固第VIII因子のグローバル市場 2021年：企業別、地域別、種類・用途別

• 英文タイトル：Global Human Coagulation Factor VIII Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-203B16416
• 出版社/出版日：GlobalInfoResearch / 2021年12月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

ヒト血液凝固第VIII因子市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のヒト血液凝固第VIII因子の市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界のヒト血液凝固第VIII因子の市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。

ヒト血液凝固第VIII因子市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・遺伝子組換え第VIII因子、血漿由来第VIII因子

用途別セグメントは次のように区分されます。
・血友病A、自発的/外傷、外科的、その他

世界のヒト血液凝固第VIII因子市場の主要な市場プレーヤーは以下のとおりです。
・Shire (Baxter)、Bayer、CSL、Pfizer、Grifols、Biogen、Octapharma、NovoNordisk、Greencross、Kedrion、BPL、Hualan Bio、RAAS

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計14章あります。
・第1章では、ヒト血液凝固第VIII因子製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なヒト血液凝固第VIII因子メーカーの企業概要、2019年～2021年までのヒト血液凝固第VIII因子の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なヒト血液凝固第VIII因子メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2016年～2026年までの地域別ヒト血液凝固第VIII因子の販売量、売上、成長性を示しています。
・第5、6章では、2016年～2026年までのヒト血液凝固第VIII因子の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域でのヒト血液凝固第VIII因子市場予測を収録しています。
・第12、13、14章では、ヒト血液凝固第VIII因子の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Shire (Baxter)、Bayer、CSL、Pfizer、Grifols、Biogen、Octapharma、NovoNordisk、Greencross、Kedrion、BPL、Hualan Bio、RAAS
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年：遺伝子組換え第VIII因子、血漿由来第VIII因子
・用途別分析2016年-2026年：血友病A、自発的/外傷、外科的、その他
・ヒト血液凝固第VIII因子の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ
・ヒト血液凝固第VIII因子のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア
・ヒト血液凝固第VIII因子のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア
・ヒト血液凝固第VIII因子の南米市場規模2016年-2026年：ブラジル、アルゼンチン
・ヒト血液凝固第VIII因子の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Human Coagulation Factor VIII market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Human Coagulation Factor VIII size is estimated to be XX million in 2021 from USD 9829.6 million in 2020, with a change of XX% between 2020 and 2021. The global Human Coagulation Factor VIII market size is expected to grow at a CAGR of 6.0% for the next five years.

Market segmentation
Human Coagulation Factor VIII market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Recombinant Factor VIII
Plasma-derived Factor VIII

Market segment by Application can be divided into
Hemophilia A
Spontanous / Trauma
Surgical
Other

The key market players for global Human Coagulation Factor VIII market are listed below:
Shire (Baxter)
Bayer
CSL
Pfizer
Grifols
Biogen
Octapharma
NovoNordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Human Coagulation Factor VIII product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Coagulation Factor VIII, with price, sales, revenue and global market share of Human Coagulation Factor VIII from 2019 to 2021.
Chapter 3, the Human Coagulation Factor VIII competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Coagulation Factor VIII breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Human Coagulation Factor VIII market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Human Coagulation Factor VIII sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Human Coagulation Factor VIII Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Coagulation Factor VIII Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Recombinant Factor VIII
1.2.3 Plasma-derived Factor VIII
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Coagulation Factor VIII Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hemophilia A
1.3.3 Spontanous / Trauma
1.3.4 Surgical
1.3.5 Other
1.4 Global Human Coagulation Factor VIII Market Size & Forecast
1.4.1 Global Human Coagulation Factor VIII Sales in Value (2016-2026))
1.4.2 Global Human Coagulation Factor VIII Sales in Volume (2016-2026)
1.4.3 Global Human Coagulation Factor VIII Price by Type (2016-2026) & (USD/Bottle)
1.5 Global Human Coagulation Factor VIII Production Capacity Analysis
1.5.1 Global Human Coagulation Factor VIII Total Production Capacity (2016-2026)
1.5.2 Global Human Coagulation Factor VIII Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Coagulation Factor VIII Market Drivers
1.6.2 Human Coagulation Factor VIII Market Restraints
1.6.3 Human Coagulation Factor VIII Trends Analysis
2 Manufacturers Profiles
2.1 Shire (Baxter)
2.1.1 Shire (Baxter) Details
2.1.2 Shire (Baxter) Major Business
2.1.3 Shire (Baxter) Human Coagulation Factor VIII Product and Services
2.1.4 Shire (Baxter) Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer Human Coagulation Factor VIII Product and Services
2.2.4 Bayer Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 CSL
2.3.1 CSL Details
2.3.2 CSL Major Business
2.3.3 CSL Human Coagulation Factor VIII Product and Services
2.3.4 CSL Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Human Coagulation Factor VIII Product and Services
2.4.4 Pfizer Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Grifols
2.5.1 Grifols Details
2.5.2 Grifols Major Business
2.5.3 Grifols Human Coagulation Factor VIII Product and Services
2.5.4 Grifols Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Biogen
2.6.1 Biogen Details
2.6.2 Biogen Major Business
2.6.3 Biogen Human Coagulation Factor VIII Product and Services
2.6.4 Biogen Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Octapharma
2.7.1 Octapharma Details
2.7.2 Octapharma Major Business
2.7.3 Octapharma Human Coagulation Factor VIII Product and Services
2.7.4 Octapharma Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 NovoNordisk
2.8.1 NovoNordisk Details
2.8.2 NovoNordisk Major Business
2.8.3 NovoNordisk Human Coagulation Factor VIII Product and Services
2.8.4 NovoNordisk Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Greencross
2.9.1 Greencross Details
2.9.2 Greencross Major Business
2.9.3 Greencross Human Coagulation Factor VIII Product and Services
2.9.4 Greencross Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Kedrion
2.10.1 Kedrion Details
2.10.2 Kedrion Major Business
2.10.3 Kedrion Human Coagulation Factor VIII Product and Services
2.10.4 Kedrion Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 BPL
2.11.1 BPL Details
2.11.2 BPL Major Business
2.11.3 BPL Human Coagulation Factor VIII Product and Services
2.11.4 BPL Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Hualan Bio
2.12.1 Hualan Bio Details
2.12.2 Hualan Bio Major Business
2.12.3 Hualan Bio Human Coagulation Factor VIII Product and Services
2.12.4 Hualan Bio Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 RAAS
2.13.1 RAAS Details
2.13.2 RAAS Major Business
2.13.3 RAAS Human Coagulation Factor VIII Product and Services
2.13.4 RAAS Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Human Coagulation Factor VIII Sales by Manufacturer
3.1 Global Human Coagulation Factor VIII Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Human Coagulation Factor VIII Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Human Coagulation Factor VIII
3.4 Market Concentration Rate
3.4.1 Top 3 Human Coagulation Factor VIII Manufacturer Market Share
3.4.2 Top 6 Human Coagulation Factor VIII Manufacturer Market Share
3.5 Global Human Coagulation Factor VIII Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Human Coagulation Factor VIII Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Human Coagulation Factor VIII Market Size by Region
4.1.1 Global Human Coagulation Factor VIII Sales in Volume by Region (2016-2026)
4.1.2 Global Human Coagulation Factor VIII Revenue by Region (2016-2026)
4.2 North America Human Coagulation Factor VIII Revenue (2016-2026)
4.3 Europe Human Coagulation Factor VIII Revenue (2016-2026)
4.4 Asia-Pacific Human Coagulation Factor VIII Revenue (2016-2026)
4.5 South America Human Coagulation Factor VIII Revenue (2016-2026)
4.6 Middle East and Africa Human Coagulation Factor VIII Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Human Coagulation Factor VIII Sales in Volume by Type (2016-2026)
5.2 Global Human Coagulation Factor VIII Revenue by Type (2016-2026)
5.3 Global Human Coagulation Factor VIII Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Human Coagulation Factor VIII Sales in Volume by Application (2016-2026)
6.2 Global Human Coagulation Factor VIII Revenue by Application (2016-2026)
6.3 Global Human Coagulation Factor VIII Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Human Coagulation Factor VIII Sales by Type (2016-2026)
7.2 North America Human Coagulation Factor VIII Sales by Application (2016-2026)
7.3 North America Human Coagulation Factor VIII Market Size by Country
7.3.1 North America Human Coagulation Factor VIII Sales in Volume by Country (2016-2026)
7.3.2 North America Human Coagulation Factor VIII Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Human Coagulation Factor VIII Sales by Type (2016-2026)
8.2 Europe Human Coagulation Factor VIII Sales by Application (2016-2026)
8.3 Europe Human Coagulation Factor VIII Market Size by Country
8.3.1 Europe Human Coagulation Factor VIII Sales in Volume by Country (2016-2026)
8.3.2 Europe Human Coagulation Factor VIII Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Human Coagulation Factor VIII Sales by Type (2016-2026)
9.2 Asia-Pacific Human Coagulation Factor VIII Sales by Application (2016-2026)
9.3 Asia-Pacific Human Coagulation Factor VIII Market Size by Region
9.3.1 Asia-Pacific Human Coagulation Factor VIII Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Human Coagulation Factor VIII Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Human Coagulation Factor VIII Sales by Type (2016-2026)
10.2 South America Human Coagulation Factor VIII Sales by Application (2016-2026)
10.3 South America Human Coagulation Factor VIII Market Size by Country
10.3.1 South America Human Coagulation Factor VIII Sales in Volume by Country (2016-2026)
10.3.2 South America Human Coagulation Factor VIII Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Human Coagulation Factor VIII Sales by Type (2016-2026)
11.2 Middle East & Africa Human Coagulation Factor VIII Sales by Application (2016-2026)
11.3 Middle East & Africa Human Coagulation Factor VIII Market Size by Country
11.3.1 Middle East & Africa Human Coagulation Factor VIII Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Human Coagulation Factor VIII Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Human Coagulation Factor VIII Typical Distributors
12.3 Human Coagulation Factor VIII Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Human Coagulation Factor VIII Revenue by Type, (USD Million), 2021-2026
Table 2. Global Human Coagulation Factor VIII Revenue by Application, (USD Million), 2021-2026
Table 3. Shire (Baxter) Basic Information, Manufacturing Base and Competitors
Table 4. Shire (Baxter) Major Business
Table 5. Shire (Baxter) Human Coagulation Factor VIII Product and Services
Table 6. Shire (Baxter) Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Bayer Basic Information, Manufacturing Base and Competitors
Table 8. Bayer Major Business
Table 9. Bayer Human Coagulation Factor VIII Product and Services
Table 10. Bayer Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. CSL Basic Information, Manufacturing Base and Competitors
Table 12. CSL Major Business
Table 13. CSL Human Coagulation Factor VIII Product and Services
Table 14. CSL Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Pfizer Basic Information, Manufacturing Base and Competitors
Table 16. Pfizer Major Business
Table 17. Pfizer Human Coagulation Factor VIII Product and Services
Table 18. Pfizer Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Grifols Basic Information, Manufacturing Base and Competitors
Table 20. Grifols Major Business
Table 21. Grifols Human Coagulation Factor VIII Product and Services
Table 22. Grifols Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Biogen Basic Information, Manufacturing Base and Competitors
Table 24. Biogen Major Business
Table 25. Biogen Human Coagulation Factor VIII Product and Services
Table 26. Biogen Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Octapharma Basic Information, Manufacturing Base and Competitors
Table 28. Octapharma Major Business
Table 29. Octapharma Human Coagulation Factor VIII Product and Services
Table 30. Octapharma Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. NovoNordisk Basic Information, Manufacturing Base and Competitors
Table 32. NovoNordisk Major Business
Table 33. NovoNordisk Human Coagulation Factor VIII Product and Services
Table 34. NovoNordisk Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Greencross Basic Information, Manufacturing Base and Competitors
Table 36. Greencross Major Business
Table 37. Greencross Human Coagulation Factor VIII Product and Services
Table 38. Greencross Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Kedrion Basic Information, Manufacturing Base and Competitors
Table 40. Kedrion Major Business
Table 41. Kedrion Human Coagulation Factor VIII Product and Services
Table 42. Kedrion Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. BPL Basic Information, Manufacturing Base and Competitors
Table 44. BPL Major Business
Table 45. BPL Human Coagulation Factor VIII Product and Services
Table 46. BPL Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 48. Hualan Bio Major Business
Table 49. Hualan Bio Human Coagulation Factor VIII Product and Services
Table 50. Hualan Bio Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. RAAS Basic Information, Manufacturing Base and Competitors
Table 52. RAAS Major Business
Table 53. RAAS Human Coagulation Factor VIII Product and Services
Table 54. RAAS Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Global Human Coagulation Factor VIII Sales by Manufacturer (2019-2021e) & (K Bottles)
Table 56. Global Human Coagulation Factor VIII Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 57. Market Position of Manufacturers in Human Coagulation Factor VIII, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 58. Global Human Coagulation Factor VIII Production Capacity by Company, (K Bottles): 2020 VS 2021
Table 59. Head Office and Human Coagulation Factor VIII Production Site of Key Manufacturer
Table 60. Human Coagulation Factor VIII New Entrant and Capacity Expansion Plans
Table 61. Human Coagulation Factor VIII Mergers & Acquisitions in the Past Five Years
Table 62. Global Human Coagulation Factor VIII Sales by Region (2016-2021e) & (K Bottles)
Table 63. Global Human Coagulation Factor VIII Sales by Region (2021-2026) & (K Bottles)
Table 64. Global Human Coagulation Factor VIII Revenue by Region (2016-2021e) & (USD Million)
Table 65. Global Human Coagulation Factor VIII Revenue by Region (2021-2026) & (USD Million)
Table 66. Global Human Coagulation Factor VIII Sales by Type (2016-2021e) & (K Bottles)
Table 67. Global Human Coagulation Factor VIII Sales by Type (2021-2026) & (K Bottles)
Table 68. Global Human Coagulation Factor VIII Revenue by Type (2016-2021e) & (USD Million)
Table 69. Global Human Coagulation Factor VIII Revenue by Type (2021-2026) & (USD Million)
Table 70. Global Human Coagulation Factor VIII Price by Type (2016-2021e) & (USD/Bottle)
Table 71. Global Human Coagulation Factor VIII Price by Type (2021-2026) & (USD/Bottle)
Table 72. Global Human Coagulation Factor VIII Sales by Application (2016-2021e) & (K Bottles)
Table 73. Global Human Coagulation Factor VIII Sales by Application (2021-2026) & (K Bottles)
Table 74. Global Human Coagulation Factor VIII Revenue by Application (2016-2021e) & (USD Million)
Table 75. Global Human Coagulation Factor VIII Revenue by Application (2021-2026) & (USD Million)
Table 76. Global Human Coagulation Factor VIII Price by Application (2016-2021e) & (USD/Bottle)
Table 77. Global Human Coagulation Factor VIII Price by Application (2021-2026) & (USD/Bottle)
Table 78. North America Human Coagulation Factor VIII Sales by Country (2016-2021e) & (K Bottles)
Table 79. North America Human Coagulation Factor VIII Sales by Country (2021-2026) & (K Bottles)
Table 80. North America Human Coagulation Factor VIII Revenue by Country (2016-2021e) & (USD Million)
Table 81. North America Human Coagulation Factor VIII Revenue by Country (2021-2026) & (USD Million)
Table 82. North America Human Coagulation Factor VIII Sales by Type (2016-2021e) & (K Bottles)
Table 83. North America Human Coagulation Factor VIII Sales by Type (2021-2026) & (K Bottles)
Table 84. North America Human Coagulation Factor VIII Sales by Application (2016-2021e) & (K Bottles)
Table 85. North America Human Coagulation Factor VIII Sales by Application (2021-2026) & (K Bottles)
Table 86. Europe Human Coagulation Factor VIII Sales by Country (2016-2021e) & (K Bottles)
Table 87. Europe Human Coagulation Factor VIII Sales by Country (2021-2026) & (K Bottles)
Table 88. Europe Human Coagulation Factor VIII Revenue by Country (2016-2021e) & (USD Million)
Table 89. Europe Human Coagulation Factor VIII Revenue by Country (2021-2026) & (USD Million)
Table 90. Europe Human Coagulation Factor VIII Sales by Type (2016-2021e) & (K Bottles)
Table 91. Europe Human Coagulation Factor VIII Sales by Type (2021-2026) & (K Bottles)
Table 92. Europe Human Coagulation Factor VIII Sales by Application (2016-2021e) & (K Bottles)
Table 93. Europe Human Coagulation Factor VIII Sales by Application (2021-2026) & (K Bottles)
Table 94. Asia-Pacific Human Coagulation Factor VIII Sales by Region (2016-2021e) & (K Bottles)
Table 95. Asia-Pacific Human Coagulation Factor VIII Sales by Region (2021-2026) & (K Bottles)
Table 96. Asia-Pacific Human Coagulation Factor VIII Revenue by Region (2016-2021e) & (USD Million)
Table 97. Asia-Pacific Human Coagulation Factor VIII Revenue by Region (2021-2026) & (USD Million)
Table 98. Asia-Pacific Human Coagulation Factor VIII Sales by Type (2016-2021e) & (K Bottles)
Table 99. Asia-Pacific Human Coagulation Factor VIII Sales by Type (2021-2026) & (K Bottles)
Table 100. Asia-Pacific Human Coagulation Factor VIII Sales by Application (2016-2021e) & (K Bottles)
Table 101. Asia-Pacific Human Coagulation Factor VIII Sales by Application (2021-2026) & (K Bottles)
Table 102. South America Human Coagulation Factor VIII Sales by Country (2016-2021e) & (K Bottles)
Table 103. South America Human Coagulation Factor VIII Sales by Country (2021-2026) & (K Bottles)
Table 104. South America Human Coagulation Factor VIII Revenue by Country (2016-2021e) & (USD Million)
Table 105. South America Human Coagulation Factor VIII Revenue by Country (2021-2026) & (USD Million)
Table 106. South America Human Coagulation Factor VIII Sales by Type (2016-2021e) & (K Bottles)
Table 107. South America Human Coagulation Factor VIII Sales by Type (2021-2026) & (K Bottles)
Table 108. South America Human Coagulation Factor VIII Sales by Application (2016-2021e) & (K Bottles)
Table 109. South America Human Coagulation Factor VIII Sales by Application (2021-2026) & (K Bottles)
Table 110. Middle East & Africa Human Coagulation Factor VIII Sales by Country (2016-2021e) & (K Bottles)
Table 111. Middle East & Africa Human Coagulation Factor VIII Sales by Country (2021-2026) & (K Bottles)
Table 112. Middle East & Africa Human Coagulation Factor VIII Revenue by Country (2016-2021e) & (USD Million)
Table 113. Middle East & Africa Human Coagulation Factor VIII Revenue by Country (2021-2026) & (USD Million)
Table 114. Middle East & Africa Human Coagulation Factor VIII Sales by Type (2016-2021e) & (K Bottles)
Table 115. Middle East & Africa Human Coagulation Factor VIII Sales by Type (2021-2026) & (K Bottles)
Table 116. Middle East & Africa Human Coagulation Factor VIII Sales by Application (2016-2021e) & (K Bottles)
Table 117. Middle East & Africa Human Coagulation Factor VIII Sales by Application (2021-2026) & (K Bottles)
Table 118. Direct Channel Pros & Cons
Table 119. Indirect Channel Pros & Cons
Table 120. Human Coagulation Factor VIII Typical Distributors
Table 121. Human Coagulation Factor VIII Typical Customers
List of Figures
Figure 1. Human Coagulation Factor VIII Picture
Figure 2. Global Human Coagulation Factor VIII Sales Market Share by Type in 2020
Figure 3. Recombinant Factor VIII
Figure 4. Plasma-derived Factor VIII
Figure 5. Global Human Coagulation Factor VIII Sales Market Share by Application in 2020
Figure 6. Hemophilia A
Figure 7. Spontanous / Trauma
Figure 8. Surgical
Figure 9. Other
Figure 10. Global Human Coagulation Factor VIII Market Size, (USD Million) & (K Bottles): 2020 VS 2021 VS 2026
Figure 11. Global Human Coagulation Factor VIII Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. Global Human Coagulation Factor VIII Sales (2016-2026) & (K Bottles)
Figure 13. Global Human Coagulation Factor VIII Price by Type (2016-2026) & (USD/Bottle)
Figure 14. Global Human Coagulation Factor VIII Production Capacity (2016-2026) & (K Bottles)
Figure 15. Global Human Coagulation Factor VIII Production Capacity by Geographic Region: 2020 VS 2021
Figure 16. Human Coagulation Factor VIII Market Drivers
Figure 17. Human Coagulation Factor VIII Market Restraints
Figure 18. Human Coagulation Factor VIII Market Trends
Figure 19. Global Human Coagulation Factor VIII Sales Market Share by Manufacturer in 2020
Figure 20. Global Human Coagulation Factor VIII Revenue Market Share by Manufacturer in 2020
Figure 21. Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 22. Top 3 Human Coagulation Factor VIII Manufacturer (Revenue) Market Share in 2020
Figure 23. Top 6 Human Coagulation Factor VIII Manufacturer (Revenue) Market Share in 2020
Figure 24. Global Human Coagulation Factor VIII Sales Market Share by Region (2016-2026)
Figure 25. Global Human Coagulation Factor VIII Revenue Market Share by Region (2016-2026)
Figure 26. North America Human Coagulation Factor VIII Revenue (2016-2026) & (USD Million)
Figure 27. Europe Human Coagulation Factor VIII Revenue (2016-2026) & (USD Million)
Figure 28. Asia-Pacific Human Coagulation Factor VIII Revenue (2016-2026) & (USD Million)
Figure 29. South America Human Coagulation Factor VIII Revenue (2016-2026) & (USD Million)
Figure 30. Middle East & Africa Human Coagulation Factor VIII Revenue (2016-2026) & (USD Million)
Figure 31. Global Human Coagulation Factor VIII Sales Market Share by Type (2016-2026)
Figure 32. Global Human Coagulation Factor VIII Revenue Market Share by Type (2016-2026)
Figure 33. Global Human Coagulation Factor VIII Price by Type (2016-2026) & (USD/Bottle)
Figure 34. Global Human Coagulation Factor VIII Sales Market Share by Application (2016-2026)
Figure 35. Global Human Coagulation Factor VIII Revenue Market Share by Application (2016-2026)
Figure 36. Global Human Coagulation Factor VIII Price by Application (2016-2026) & (USD/Bottle)
Figure 37. North America Human Coagulation Factor VIII Sales Market Share by Type (2016-2026)
Figure 38. North America Human Coagulation Factor VIII Sales Market Share by Application (2016-2026)
Figure 39. North America Human Coagulation Factor VIII Sales Market Share by Country (2016-2026)
Figure 40. North America Human Coagulation Factor VIII Revenue Market Share by Country (2016-2026)
Figure 41. United States Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe Human Coagulation Factor VIII Sales Market Share by Type (2016-2026)
Figure 45. Europe Human Coagulation Factor VIII Sales Market Share by Application (2016-2026)
Figure 46. Europe Human Coagulation Factor VIII Sales Market Share by Country (2016-2026)
Figure 47. Europe Human Coagulation Factor VIII Revenue Market Share by Country (2016-2026)
Figure 48. Germany Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Human Coagulation Factor VIII Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Human Coagulation Factor VIII Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Human Coagulation Factor VIII Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Human Coagulation Factor VIII Revenue Market Share by Region (2016-2026)
Figure 57. China Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Korea Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Human Coagulation Factor VIII Sales Market Share by Type (2016-2026)
Figure 64. South America Human Coagulation Factor VIII Sales Market Share by Application (2016-2026)
Figure 65. South America Human Coagulation Factor VIII Sales Market Share by Country (2016-2026)
Figure 66. South America Human Coagulation Factor VIII Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East & Africa Human Coagulation Factor VIII Sales Market Share by Type (2016-2026)
Figure 70. Middle East & Africa Human Coagulation Factor VIII Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Human Coagulation Factor VIII Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Human Coagulation Factor VIII Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Egypt Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. South Africa Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source

Global High Frequency Coagulation Electrosurgical Unit Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-203B15707 2021年12月 97Pages
高周波凝固電気手術装置市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供しま...

ヒト用経口ワクチンのグローバル市場 2021年：企業別、地域別、種類・用途別

Global Human Oral Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-203B16419 2021年12月 110Pages
ヒト用経口ワクチン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。...

人感センサーのグローバル市場 2021年：企業別、地域別、種類・用途別

Global Human Presence Sensor Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-203B08645 2021年12月 86Pages
人感センサー市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。

マテ茶のグローバル市場 2021年：企業別、地域別、種類・用途別

Global Yerba Mate Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-203B09345 2021年12月 120Pages
マテ茶市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
...

高級マッサージチェアのグローバル市場 2021年：企業別、地域別、種類・用途別

Global Luxury Massage Chair Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-203B06172 2021年12月 101Pages
高級マッサージチェア市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します...

インスリンのグローバル市場 2021年：企業別、地域別、種類・用途別

Global Insulin Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-203B16438 2021年12月 91Pages
インスリン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。

フィブリノゲンのグローバル市場 2021年：企業別、地域別、種類・用途別

Global Fibrinogen Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-203B16164 2021年12月 95Pages
フィブリノゲン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。

縫合糸のグローバル市場 2021年：企業別、地域別、種類・用途別

Global Suture Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-203B15447 2021年12月 124Pages
縫合糸市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
...

酢酸ヒドロコルチゾンのグローバル市場 2021年：企業別、地域別、種類・用途別

Global Hydrocortisone Acetate (CAS 50-03-3) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-203B05272 2021年12月 102Pages
酢酸ヒドロコルチゾン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します...

STD自己診断のグローバル市場 2021年：企業別、地域別、種類・用途別

Global Std Self Diagnostics Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-203B16399 2021年12月 103Pages
STD自己診断市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。

高周波凝固電気手術装置のグローバル市場 2021年：企業別、地域別、種類・用途別 The High Frequency Coagulation Electrosurgical Unit market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…
人感センサーのグローバル市場 2021年：企業別、地域別、種類・用途別 The Human Presence Sensor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
ヒト用経口ワクチンのグローバル市場 2021年：企業別、地域別、種類・用途別 The Human Oral Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…
マテ茶のグローバル市場 2021年：企業別、地域別、種類・用途別 The Yerba Mate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent …
高級マッサージチェアのグローバル市場 2021年：企業別、地域別、種類・用途別 The Luxury Massage Chair market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…